The Role of Nafamostat Mesylate in Continuous Renal Replacement Therapy among Patients at High Risk of Bleeding-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Role of Nafamostat Mesylate in Continuous Renal Replacement Therapy among Patients at High Risk of Bleeding

Published:2012-01-17 Issue:3 Volume:34 Page:279-285
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Baek Na Na,Jang Hye Ryoun,Huh Wooseong,Kim Yoon-Goo,Kim Dae Joong,Oh Ha Young,Lee Jung Eun

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0886022X.2011.647293

Reference25 articles.

1. Extracorporeal treatment of acute renal failure in the intensive care unit: a critical view

2. Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation

3. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage.

4. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Dose Continuous Kidney Replacement Therapy and Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Cohort Study;American Journal of Kidney Diseases;2024-08

2. The role of nafamostat mesylate anticoagulation in continuous kidney replacement therapy for critically ill patients with bleeding tendencies: a retrospective study on patient outcomes and safety;Kidney Research and Clinical Practice;2024-07-31

3. Anticoagulation Strategies During ECMO Application;Evolving Therapies and Technologies in Extracorporeal Membrane Oxygenation [Working Title];2024-06-05

4. Amniotic fluid embolism rescued using venoarterial extracorporeal membrane oxygenation without initial anticoagulation: A case report and literature review;Medicine;2024-05-17

5. Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study;BMC Nephrology;2024-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3